Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Christina C N Wu"'
Autor:
Diana Gumber, Myan Do, Neya Suresh Kumar, Pooja R Sonavane, Christina C N Wu, Luisjesus S Cruz, Stephanie Grainger, Dennis Carson, Terry Gaasterland, Karl Willert
Publikováno v:
eLife, Vol 9 (2020)
WNT proteins are secreted symmetry breaking signals that interact with cell surface receptors of the FZD family to regulate a multitude of developmental processes. Studying selectivity between WNTs and FZDs has been hampered by the paucity of purifie
Externí odkaz:
https://doaj.org/article/988e7a735dd744bdb503d91be2727265
Autor:
Sanghee Lee, Theresa R. Mendoza, Danielle N. Burner, Michelle T. Muldong, Christina C. N. Wu, Catalina Arreola-Villanueva, Abril Zuniga, Olga Greenburg, William Y. Zhu, Jamillah Murtadha, Evodie Koutouan, Naomi Pineda, Hao Pham, Sung-Gu Kang, Hyun Tae Kim, Gabriel Pineda, Kathleen M. Lennon, Nicholas A. Cacalano, Catriona H. M. Jamieson, Christopher J. Kane, Anna A. Kulidjian, Terry Gaasterland, Christina A. M. Jamieson
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 6, p 3203 (2022)
Advanced prostate cancer (PCa) patients with bone metastases are treated with androgen pathway directed therapy (APDT). However, this treatment invariably fails and the cancer becomes castration resistant. To elucidate resistance mechanisms and to pr
Externí odkaz:
https://doaj.org/article/74dca8cc2277473d8d96fa0281e4926c
Autor:
Zhongke Hua, Yu Han, Kan Liu, Hua Yang, Cai Zhou, Fengyi Chen, Shenglan Nie, Mengqing Li, Qinyao Yu, Yunpeng Wei, Christina C. N. Wu, Xiaomei Wang
Publikováno v:
Frontiers in oncology. 12
The resistant cells that proliferate after radiotherapy and chemotherapy are primarily tumor stem cells with high stem marker expression, and their presence is the primary cause of tumor dispersion. The Wnt signaling receptor Frizzled family receptor
Autor:
Sanghee Lee, Theresa R. Mendoza, Danielle N. Burner, Michelle T. Muldong, Christina C. N. Wu, Catalina Arreola-Villanueva, Abril Zuniga, Olga Greenburg, William Y. Zhu, Jamillah Murtadha, Evodie Koutouan, Naomi Pineda, Hao Pham, Sung-Gu Kang, Hyun Tae Kim, Gabriel Pineda, Kathleen M. Lennon, Nicholas A. Cacalano, Catriona H. M. Jamieson, Christopher J. Kane, Anna A. Kulidjian, Terry Gaasterland, Christina A. M. Jamieson
Publikováno v:
International journal of molecular sciences, vol 23, iss 6
International Journal of Molecular Sciences; Volume 23; Issue 6; Pages: 3203
International Journal of Molecular Sciences; Volume 23; Issue 6; Pages: 3203
Advanced prostate cancer (PCa) patients with bone metastases are treated with androgen pathway directed therapy (APDT). However, this treatment invariably fails and the cancer becomes castration resistant. To elucidate resistance mechanisms and to pr
Autor:
Christina Jamieson, Sung Chang Lee, Jennifer Ma, Sean B. Joseph, Minsoo Kim, Anna A. Kulidjian, Peter G. Schultz, Ashley K. Woods, Wenxue Ma, Mike Petrassi, Michelle Muldong, Travis S. Young, Hwayoung Yun, Christopher J. Kane, Eric N. Hampton, Chan Hyuk Kim, Jing Li, Vanessa Núñez, Eduardo Laborda, Klyushnichenko Vadim, Sei-hyun Choi, John Wisler, Christina C. N. Wu
Publikováno v:
Science Advances
Science advances, vol 7, iss 33
Science advances, vol 7, iss 33
CCW702 is a bispecific antibody that combines the specificity of an imaging ligand with the potency of a T cell immunotherapy.
Despite the development of next-generation antiandrogens, metastatic castration-resistant prostate cancer (mCRPC) rema
Despite the development of next-generation antiandrogens, metastatic castration-resistant prostate cancer (mCRPC) rema
Autor:
Gaixia Xu, Desheng Lu, Kan Liu, Jiangyao Xu, Maixian Liu, Christina C. N. Wu, Yang Li, Guangyi Jin, Zijun Ouyang, Wenxiao Jiang, Shikang Liu, Xiaomei Wang, Xingsheng Shu, Guimiao Lin, Meiyi Chen
Background: Malignant tumors express multiple common markers that might constitute targets for tumor immunotherapy. Methods: Here we performed antigen epitope screening and molecular docking to design a new combination vaccine based on covalently lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b363debcd984f976b695e61c66189b7
https://doi.org/10.21203/rs.3.rs-147864/v1
https://doi.org/10.21203/rs.3.rs-147864/v1
Autor:
Terry Gaasterland, William Zhu, Sanghee Lee, Christina Jamieson, Kathleen M. Lennon, Abril Zuniga, Olga Miakicheva-Greenburg, Theresa Mendoza, Anna A. Kulidjian, Michelle Muldong, Christopher J. Kane, Catalina Arreola, Danielle Burner, Catriona Jamieson, Nicholas A. Cacalano, Gabriel Pineda, Christina C. N. Wu
Publikováno v:
SSRN Electronic Journal.
Advanced prostate cancer (PCa) patients with bone metastases are treated standardly with Androgen Pathway Directed Therapy (APDT), however, they invariably become APDT-resistant. To elucidate resistance mechanisms and to provide more predictive pre-c
Autor:
Christina C. N. Wu, Christopher J. Kane, Theresa Mendoza, Sanghee Lee, Nicholas A. Cacalano, Anna A. Kulidjian, Danielle Burner, Catalina Arreola, Michelle Muldong, Christina Jamieson
Publikováno v:
Journal of Visualized Experiments.
Three-dimensional (3D) culture of organoids from tumor specimens of human patients and patient-derived xenograft (PDX) models of prostate cancer, referred to as patient-derived organoids (PDO), are an invaluable resource for studying the mechanism of
Autor:
Robert L. Sah, Seung Chol Park, Catriona Jamieson, Amy Strasner, Nicholas A. Cacalano, Christopher J. Kane, Hiromi Kumon, Koichi Masuda, Christina C. N. Wu, Christina Jamieson, Anna A. Kulidjian, Omer A. Raheem, Michelle Muldong, Takeshi Hirata, Tomonori Yamaguchi
Publikováno v:
Asian Journal of Urology, Vol 3, Iss 4, Pp 229-239 (2016)
Asian journal of urology, vol 3, iss 4
Asian Journal of Urology
Asian journal of urology, vol 3, iss 4
Asian Journal of Urology
Objective: Bone metastasis occurs in up to 90% of men with advanced prostate cancer and leads to fractures, severe pain and therapy-resistance. Bone metastases induce a spectrum of types of bone lesions which can respond differently to therapy even w
Autor:
Danielle Burner, Christopher J. Kane, Catriona Jamieson, Christina C. N. Wu, Nicholas A. Cacalano, Anna A. Kulidjian, Christina Jamieson, Michelle Muldong, Sanghee Lee, Theresa Mendoza, Catalina Arreola, Abril Zuniga
Publikováno v:
Cancer Research. 80:6109-6109
Background: Upon diagnosis of castration-resistant prostate cancer (CRPC), 84% of patients present with metastases and their survival rate is 28% despite improvements in treatment options. PCSD1, a patient-derived xenograft from a prostate cancer bon